TAS-102 has a tumoricidal activity in multiple myeloma

Li, GL; Liu, H; He, J; Li, ZW; Wang, ZM; Zhou, S; Zheng, GP; He, ZM; Yang, J

Liu, H; Yang, J (corresponding author), Houston Methodist Hosp, Res Inst, Ctr Hematol Malignancy, Houston, TX 77030 USA.

AMERICAN JOURNAL OF CANCER RESEARCH, 2020; 10 (11): 3752

Abstract

TAS-102/Lonsurf is a new oral anti-tumor drug consisting of trifluridine and tipiracil in a 1:0.5 molar ratio. Lonsurf has been approved globally, inc......

Full Text Link